Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response

Journal of Proteome Research

Volumn 8, Issue 7, 2009, Pages 3578-3587

  Wikoff, William R ^a   Kalisak, Ewa ^a   Trauger, Sunia ^a   Manchester, Marianne ^b   Siuzdak, Gary ^a  

^a Scripps Center for Mass Spectrometry   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Innate immunity; Mass spectrometry; Metabolism; Systems biology; Untargeted metabolomics

Indexed keywords

2 OXOGLUTARIC ACID; ACONITIC ACID; BIOPTERIN; CITRIC ACID; FATTY ACID; GAMMA INTERFERON; KYNURENINE; LYSOPHOSPHATIDYLCHOLINE; NEOPTERIN; SUCCINIC ACID; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELLULAR IMMUNITY; CITRIC ACID CYCLE; CONTROLLED STUDY; CONVALESCENCE; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; VIRUS CELL INTERACTION;

ANIMALS; BLOOD PROTEINS; IMMUNITY, INNATE; INTERFERON-GAMMA; KINETICS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MODELS, CHEMICAL; SYSTEMS BIOLOGY;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

EID: 67650400646     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900275p     Document Type: Article

References (44)

1. Oldstone, M. B. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 2002, 263, 83-117.
2. Buchmeier, M. J.; Welsh, R. M.; Dutko, F. J.; Oldstone, M. B. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 1980, 30, 275-331.
3. Guidotti, L. G.; Borrow, P.; Brown, A.; McClary, H.; Koch, R.; Chisari, F. V. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 1999, 189 (10), 1555-1564.
4. Welsh, R. M. Cytotoxic cells induced during lymphocytic choriomeningitis virus-infection of mice 0.1. Characterization of natural killer cell induction. J. Exp. Med. 1978, 148 (1), 163-181.
5. Zuniga, E. I.; Hahm, B.; Oldstone, M. B. Type I interferon during viral infections: multiple triggers for a multifunctional mediator. Curr. Top. Microbiol. Immunol. 2007, 316, 337-57.
6. Kunz, S.; Rojek, J. M.; Roberts, A. J.; McGavern, D. B.; Oldstone, M. B.; de la Torre, J. C. Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. J. Virol. 2006, 80 (18), 9082-9092.
7. Orange, J. S.; Biron, C. A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 1996, 156 (3), 1138-1142.
8. Cousens, L. P.; Orange, J. S.; Su, H. C.; Biron, C. A. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (2), 634-639.
9. Go, E. P.; Wikoff, W. R.; Shen, Z. X.; O'Maille, G.; Morita, H.; Conrads, T. P.; Nordstrom, A.; Trauger, S. A.; Uritboonthai, W.; Lucas, D. A.; Chan, K. C.; Veenstra, T. D.; Lewicki, H.; Oldstone, M. B.; Schneemann, A.; Siuzdak, G. Mass spectrometry reveals specific and global molecular transformations during viral infection. J. Proteome Res. 2006, 5 (9), 2405-2416.
10. Munger, J.; Bajad, S. U.; Coller, H. A.; Shenk, T.; Rabinowitz, J. D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2 (12), 1165-1175.
11. Wikoff, W. R.; Pendyala, G.; Siuzdak, G.; Fox, H. S. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J. Clin Invest. 2008, 118 (7), 2661-2669.
12. Yasui, H.; Takai, K.; Yoshida, R.; Hayaishi, O. Interferon enhances tryptophan-metabolism by inducing pulmonary indoleamine 2,3-dioxygenasesits possible occurrence in cancer-patients. Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (17), 6622-6626.
13. Dutko, F. J.; Oldstone, M. B. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 1983, 64 (Pt. 8), 1689-98.
14. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78 (3), 779-787.
15. Smith, C. A.; O'Maille, G.; Want, E. J.; Qin, C.; Trauger, S. A.; Brandon, T. R.; Custodio, D. E.; Abagyan, R.; Siuzdak, G. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 2005, 27 (6), 747-751.
16. Fahy, E.; Sud, M.; Cotter, D.; Subramaniam, S. LIPID MAPS online tools for lipid research. Nucleic Acids Res. 2007, 35, W606-12.
17. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; Macinnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007, 35, D521-526.
18. Kanehisa, M.; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28 (1), 27-30.
19. Harrison, A. G. Characterization of alpha- and gamma-glutamyl dipeptides by negative ion collision-induced dissociation. J. Mass Spectrom. 2004, 39 (2), 136-144.
20. Tammen, H.; Peck, A.; Budde, P.; Zucht, H. D. Peptidomics analysis of human blood specimens for biomarker discovery. Expert Rev. Mol. Diagn. 2007, 7 (5), 605-613.
21. Buchanan, D. L.; Haley, E. E.; Markiw, R. T. Occurrence of beta-aspartyl and gamma-glutamyl oligopeptides in human urine. Biochemistry 1962, 1, 612-620.
22. Reichelt, K. L. The isolation of gamma-glutamyl peptides from monkey brain. J. Neurochem. 1970, 17 (1), 19-25.
23. Chen, C.; Shah, Y. M.; Morimura, K.; Krausz, K. W.; Miyazaki, M.; Richardson, T. A.; Morgan, E. T.; Ntambi, J. M.; Idle, J. R.; Gonzalez, F. J. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 2008, 7 (2), 135-147.
24. Dennis, E. A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 1994, 269 (18), 13057-13060.
25. Yang, J.; Zhao, X. J.; Liu, X. L.; Wang, C.; Gao, P.; Wang, J. S.; Li, L. J.; Gu, J. R.; Yang, S. L.; Xu, G. W. High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J. Proteome Res. 2006, 5 (3), 554-561.
26. Kabarowski, J. H.; Xu, Y.; Witte, O. N. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 2002, 64 (2), 161-167.
27. Drobnik, W.; Liebisch, G.; Audebert, F. X.; Frohlich, D.; Gluck, T.; Vogel, P.; Rothe, G.; Schmitz, G. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J. Lipid Res. 2003, 44 (4), 754-761.
28. Yan, J. J.; Jung, J. S.; Lee, J. E.; Lee, J.; Huh, S. O.; Kim, H. S.; Jung, K. C.; Cho, J. Y.; Nam, J. S.; Suh, H. W.; Kim, Y. H.; Song, D. K. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 2004, 10 (2), 161-167.
29. Murch, O.; Collin, M.; Sepodes, B.; Foster, S. J.; Mota-Filipe, H.; Thiemermann, C. Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock. Br. J. Pharmacol. 2006, 148 (6), 769-777.
30. Zhao, Z. W.; Xiao, Y. J.; Elson, P.; Tan, H. Y.; Plummer, S. J.; Berk, M.; Aung, P. P.; Lavery, I. C.; Achkar, J. P.; Li, L.; Casey, G.; Xu, Y. Plasma lysophosphatidylcholine levels: Potential biomarkers for colorectal cancer. J. Clin. Oncol. 2007, 25 (19), 2696-2701.
31. Okita, M.; Gaudette, D. C.; Mills, G. B.; Holub, B. J. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. Int. J. Cancer 1997, 71 (1), 31-34.
32. Gregersen, N.; Mortensen, P. B.; Kolvraa, S. On the biologic origin of C6-C10-dicarboxylic and C6-C10-omega-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: in vitro studies on the omega- and omega-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver. Pediatr. Res. 1983, 17 (10), 828-834.
33. Williams, R. E.; Major, H.; Lock, E. A.; Lenz, E. M.; Wilson, I. D. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. Toxicology 2005, 207 (2), 179-190.
34. Bjorkhem, I.; Blomstrand, S.; Haga, P.; Kase, B. F.; Palonek, E.; Pedersen, J. I.; Strandvik, B.; Wikstrom, S. A. Urinary excretion of dicarboxylic acids from patients with the Zellweger syndrome. Importance of peroxisomes in beta-oxidation of dicarboxylic acids. Biochim. Biophys. Acta 1984, 795 (1), 15-19.
35. Li, P.; Yin, Y. L.; Li, D.; Kim, S. W.; Wu, G. Amino acids and immune function. Br. J. Nutr. 2007, 98 (2), 237-252.
36. Schrocksnadel, K.; Wirleitner, B.; Winkler, C.; Fuchs, D. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta 2006, 364 (1-2), 82-90.
37. Huber, C.; Batchelor, J. R.; Fuchs, D.; Hausen, A.; Lang, A.; Niederwieser, D.; Reibnegger, G.; Swetly, P.; Troppmair, J.; Wachter, H. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 1984, 160 (1), 310-316.
38. Fuchs, D.; Hausen, A.; Reibnegger, G.; Werner, E. R.; Dierich, M. P.; Wachter, H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 1988, 9 (5), 150-155.
39. Reibnegger, G.; Auhuber, I.; Fuchs, D.; Hausen, A.; Judmaier, G.; Prior, C.; Werner, E. R.; Wachter, H. Urinary neopterin levels in acute viral hepatitis. Hepatology 1988, 8 (4), 771-774.
40. Sghiri, R.; Feinberg, J.; Thabet, F.; Dellagi, K.; Boukadida, J.; Ben Abdelaziz, A.; Casanova, J. L.; Barbouche, M. R. Gamma interferon is dispensable for neopterin production in vivo. Clin. Diagn. Lab. Immunol. 2005, 12 (12), 1437-1441.
41. Vorbach, C.; Harrison, R.; Capecchi, M. R. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 2003, 24 (9), 512-517.
42. Peterhans, E.; Grob, M.; Burge, T.; Zanoni, R. Virus-induced formation of reactive oxygen intermediates in phagocytic cells. Free Radical Res. Commun. 1987, 3 (1-5), 39-46.
43. Yamamoto, T.; Moriwaki, Y.; Takahashi, S.; Tsutsumi, Z.; Yamakita, J.; Nasako, Y.; Hiroishi, K.; Higashino, K. Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. J. Chromatogr., B 1996, 681 (2), 395-400.
44. Rubic, T.; Lametschwandtner, G.; Jost, S.; Hinteregger, S.; Kund, J.; Carballido-Perrig, N.; Schwarzler, C.; Junt, T.; Voshol, H.; Meingassner, J. G.; Mao, X.; Werner, G.; Rot, A.; Carballido, J. M. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 2008, 9 (11), 1261-1269.